Bausch Health
BHC
#4603
Rank
NZ$4.22 B
Marketcap
NZ$11.30
Share price
0.75%
Change (1 day)
-9.32%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): NZ-$5.67

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is NZ-$5.44. In 2025 the company made an earnings per share (EPS) of NZ$0.71 an increase over its 2024 EPS that were of NZ-$0.20.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.67-904.06%
2025NZ$0.71-450%
2024NZ-$0.20-92.59%
2023NZ-$2.72160.89%
2022NZ-$1.04-76.64%
2021NZ-$4.4668.45%
2020NZ-$2.65-68.91%
2019NZ-$8.52-57.11%
2018NZ-$19.87-272.22%
2017NZ$11.54-199.29%
2016NZ-$11.62798.7%
2015NZ-$1.29-128.31%
2014NZ$4.57-204.62%
2013NZ-$4.37602.7%
2012NZ-$0.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.45-91.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.59-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA